Purchases and Sales Made in Q2 2023 in Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX) during Q2 2023. The information is specifically focused on institutions that hold shares of Syndax Pharmaceuticals Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-813K- 82.77% |
$15.7M - $18.1M
|
169K
$1.74M
|
|
|
Aug 14, 2023
Q2 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-993K- 25.7% |
$19.2M - $22.2M
|
2.87M
$29.6M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.34M- 85.0% |
$26M - $30M
|
237K
$2.44M
|